In the chicken (and in birds in general), carbohydrate and lipid metabolism and their hormonal control differ somewhat from those which operate in mammals (for reviews, see [1] and [2] ). For example, liver is the site of lipogenesis and the role of adipose tissue is mainly restricted to the storage and release of fatty acids [3] [4] [5] [6] . The basal blood glucose level of the chicken is twice that found in mammals. In the chicken, exogenous insulin at doses of 0.5-2 U/kg body weight, decreases blood glucose by 25-50% and increases simultaneously the glycogen content of the liver [7] . After partial or total pancreatectomy, chickens [8] and ducks [9, 10] generally develop severe hypoglycaemia in the fasting state, although they also exhibit impaired glucose tolerance. Therefore, birds appear to be mainly dependent on glucagon in the starved state, while remaining dependent on insulin in the fed state. Earlier studies [1] have reported that very high doses of mammalian insulin (up to 500 U/kg body weight), which are normally lethal in mammals, do not induce convulsions or kill chickens, thus suggesting that the avian species is insulin "resistant". The differences observed in carbohydrate and lipid metabolism between chickens and mammals cannot be accounted for by decreased responsiveness of the chicken B-cell to nutrients (11-13, and J. Simon, unpublished data) or by decreased potency of endogenous insulin. On the contrary, chicken insulin (and turkey insulin which possesses the same amino acid sequence as chicken insulin) are more potent than other insulins studied [14] [15] [16] . Chicken insulin also appears more potent than bovine and ovine insulins in lowering blood glucose in the chicken [7] .
The primary step in the action of insulin is binding to specific receptor sites on the plasma membrane of target cells (for review, see [17] ). We have examined the possibility that an alteration at the level of the insulin receptor may explain some of the pecularities of carbohydrate metabolism and its hormonal regulation in the chicken.
Materials and Methods

Hormones and Reagents
"Monocomponent" porcine insulin (lot n ~ MCS-970, 27.2 IU/mg) and porcine glucagon (B 66) were gifts of J. Schlichtkrull (The Novo Research Insti- I  400  1850  4750  II  352  2973  2253  840  2995  1421  1349  3057  3180 " Production of cyclic AMP is expressed as pmol/mg of membrane protein/15 min, and represents the mean of two determinations tute, Copenhagen, Denmark). The chicken insulin used was the same as that described previously [14, 15] . Porcine vasoactive intestinal polypeptide (VIP) was a gift of V. Mutt (Biokemiska Avdelningen, Karolinska Institutet, Stockholm, Sweden). Epinephrine was purchased from Calbiochem. Mono 125I-porcine insulin [18, 19] , 125I-chicken insulin [14] and mono 125I-porcine glucagon [20] were prepared as previously described. Carrier free NalZSI (preparation I-S4) was purchased from Commissariat fi l'Energie Atomique (Saclay, France). DEAE-cellulose (microgranular DE 52) was purchased from Whatman, bovine serum albumin (fraction V) from Pentex, bacitracin from Calbiochem, and kallikrein inhibitor (Trasylol) from Specia. Talc tablets (Silicosorbe, 50mg, Dreyfus Herschtel, Paris, France) were used in experiments measuring degradation of 125I-insulin [21] . Other chemicals were of reagent grade.
Membrane and Cell Isolation
Highly purified plasma membranes were prepared from livers of fed 4-5 week-old rats (120-140 g) following the method of Neville [22] and from livers of fed 3 week-old male chickens (IJV 715 or Hubbard breeds, 300-350 g) using the same method, except that the number of strokes in step 2 [22] was reduced to four instead of nine. Membranes were stored at -80 ~ C until use. The suitability of this isolation procedure for chicken liver plasma membranes was tested by measuring the activity of membrane adenylate cyclase [23] under basal and stimulated conditions. Natrium fluoride (25 mM), glucagon (1 ug/ml), epinephrine (10 gM) and VIP (1 ,ug/ml) increased the basal activity by 12-fold, 8.5-fold, 3.8-fold and 9-fold, respectively (Table 1) .
Liver cells were isolated from fed 6 week-old male chickens (Hubbard breed) following the method of Capuzzi et al. [24] . Erythrocytes were isolated from heparinized whole blood freshly drawn from fed 1-2 week-old chickens as described by others [25] , except that erythrocytes were rinsed 3 times and resuspended in the incubation buffer [26] .
Incubation Conditions for Binding Studies
Studies of insulin binding to chicken and rat liver plasma membranes were conducted at 30 ~ C in Krebs-Ringer phosphate buffer, pH 7.5, in a final volume of 0.5 ml per incubation tube that contained 125I-insulin at 0.2-0.5 ng/ml, unlabelled chicken or porcine insulin at the concentrations indicated, membrane protein [27] , 0.1-~0.3 mg/ml and bovine serum albumin, 15 mg/ml. These conditions are adequate for comparison of insulin binding in chicken and rat tissues since it has been shown that the binding characteristics (pH, temperature, negative cooperativity) of the insulin receptor in erythrocytes and erythrocyte membranes from the turkey are identical to those of the mammalian insulin receptors [28] [29] . At the end of incubation, duplicate aliquot samples from each incubation tube were transferred to microfuge tubes and membrane-bound 125I-insulin was isolated by rapid centrifugation through a washing buffer, as described previously [30] . Studies of glucagon binding [31] were conducted in the same manner except that the incubation medium contained bovine serum albumin, 24 mg/ml, bacitracin 100 ~g/ml and Trasylol 2000 IU/ml, 125I-glucagon was about 0.1 ng/ml. After 30 min at 30 o C, isolation of membrane-bound 125I-glucagon was performed as described for insulin [30] .
Studies of insulin binding to chicken liver cells [32] were conducted at 30 ~ C in 250 ~tl of KrebsRinger bicarbonate buffer (pH 7.5) that contained bovine serum albumin 30 mg/ml, 125I-insulin about 0.5 ng/ml, unlabelled chicken or porcine insulin, and hepatocytes at the concentrations indicated in figures . The cell concentration was estimated by counting two aliquot samples of the cell suspension in a Malassez chamber. Incubations were stopped by addition of 2 ml of chilled Krebs-Ringer phosphate buffer, pH 7.5, containing bovine serum albumin 10 mg/ml. Cell-bound 125I-insulin was isolated by rapid filtration on cellulose acetate (EAWP 1 ~tm) Millipore filters and rinsed twice with 4 ml of the same cold buffer [32] .
Studies of insulin binding to chicken erythrocytes were conducted at 20 ~ C or 30 ~ C in 0.5 ml of the same buffer as that used in studies of insulin binding to human blood cells [26] . The incubation medium contained 12sI-insulin 0.5 ng/ml, unlabelled porcine or chicken insulin, and erythrocytes at the concentrations indicated. At the end of incubation, duplicate aliquot samples (200 ~tl) from each incubation tube were transferred to microfuge tubes and treated in the same manner as for the isolation of membrane-bound 12sI-insulin [30] .
In all binding studies, nonspecific binding was estimated in simultaneous experiments by measuring the radioactivity bound in the presence of a large excess (50 or 100 ~g/ml) of unlabelled hormone [18, 33] . The nonspecific binding, expressed as % of the total binding 12SI-chicken or porcine insulin, represented 10-15% in chicken liver plasma membranes, 5-10% in rat liver plasma membranes, 7-20% in chicken hepatocytes and 7-15% in chicken erythrocytes. The nonspecific binding, expressed as % of the total binding of 125I-porcine glucagon represented about 10-15% in chicken liver membranes and 3-5% in rat liver membranes.
Expression of Results
The data obtained in competitive binding experiments were expressed as the percentage of initial binding (i. e., the binding of 125I-hormone in the absence of unlabelled hormone, or B0) 9 B 9 ~0 • 100. This percentage and its logit transformation were plotted against the concentration of unlabelled hormone on an arithmetic scale and on a logarithmic scale, re-B spectively (Logit y = Log ~ where y = ~ • 100). The number of specific binding sites and the corresponding apparent dissociation constants of the hormone-receptor complexes were determined from competition data at steady-state by plotting the amount of hormone specifically bound against the concentration of free hormone. The number of binding sites was also determined by Scatchard and Lineweaver-Burke plots of the same data. Statistical analyses were performed by covariance analysis [34] for the comparison of chicken and porcine insulins.
Results
Binding of Chicken and Porcine Insulin to Chicken Liver Plasma Membranes.
The time-course of binding of both 125I-porcine insulin and 125I-chicken insulin to chicken liver plasma membranes at 30 ~ C was similar (data not shown) to 221 that observed with 125I-porcine insulin binding to rat liver membranes [19, 30] . With both 125I-insulins at 0.2 ng/ml, the steady state of binding was reached after 1 hr incubation at 30 ~ C. Therefore, the binding of chicken and porcine insulin at steady state was investigated after 1 hr incubation at 30 ~ C, using either 125I-chicken or 125I-porcine insulin. The initial binding (B0), expressed as % total radioactivity, was similar with 125I-chicken and with 125I-porcine insulin: 5.4 + 0.1 and 4.6 + 0.1 (mean + SEM, n = 4), respectively, with membrane protein at 0.27 mg/ml. Both unlabelled insulins competed with the binding of either 125I-insulin (Fig. 1 ). Low concentrations (1-2 ng/ml) of unlabelled chicken and porcine insulins inhibited 5-12% of the binding of both 125I-insulins. Higher concentrations (100 ng/ml) inhibited 70-75% of the 125I-insulin binding. At concentrations lower than 100 ng/ml, chicken insulin appeared slightly more potent than porcine insulin in competing with the binding of both 125I-insulins. Logit transformation of the data gave significant (P < 0.05) regression lines within a concentration range of 2-40 ng insulin/ml (Fig. 1  right) . Chicken insulin was significantly (P < 0.05) more potent than porcine insulin when the tracer was 125I-porcine insulin.
Binding of Chicken and Porcine Insulin to Chicken Hepatocytes
The apparent steady state of binding of 125I-chicken insulin to chicken hepatocytes at 30 ~ C was reached by one hour and was stable for the subsequent 2 hr, regardless of the cell concentration (Fig. 2) . The specific binding increased with the cell concentration and represented 2.2% of total radioactivity with 3.6 • 10 6 cells/ml (Fig. 2) . Subsequent binding studies were carried out at 30 ~ C for 1 hr with about 4 x 10 6 cells/ml.
At steady state, the initial binding (B0) of 125I-chicken insulin and 125I-porcine insulin was 0.87 and 0.92% of total radioactivity when normalized at 10 6 cells/ml, respectively. Both chicken and porcine insulins inhibited the binding of either azsI-insulin (Fig. 3) . With unlabeHed insulin as low as 1 ng/ml, 125I-insulin binding was inhibited by 25-30%. Unlabelled insulin at 100 ng/ml caused 80-90% inhibition of azsI-insulin binding. Throughout the range of insulin concentrations studied, chicken and porcine insulins showed similar potencies in competing with the binding of either 12sI-insulin (Fig. 3) . Logit transformation of the data gave significant (P < 0.05) regression lines within a concentration range 2-40 ng/ml (Fig. 3, right) . 410 I00 H'~0s 2 I0 410 I00 ~NSULtN], nanograrn/rnl log ~NSULIN3j nanograrn/ml 2 ng/ml, was mixed with chicken hepatocytes at the concentrations indicated in the absence or in the presence of unlabelled hormone at 100 pg/ml. The latter was used to determine the proportion of nonspecific binding (Nonspecific binding represented 16-20% of total binding). At the indicated times, hepatocyte-bound 125I-insulin was isolated by rapid filtration on cellulose acetate (EAWP, 1.0 Fm) Millipore filters as described elsewhere [32] . Each point is the mean of two determinations
Binding of Chicken and Porcine Insulin to Chicken Ery th ro cy tes
Specific binding of 125I-porcine insulin was found in chicken erythrocytes which was dependent on cell concentration and on temperature. With cells at about 2.2 • 109/ml, i.e., a concentratio.n which is similar to that of red cells in chicken blood [35] , specific binding represented about 12.4% of total 125I-insulin and was higher at 20 o C than at 30 ~ C (Table 2) , as observed in other insulin-binding systems [32, 36] . Chicken and porcine insulins were compared in their ability to compete with the binding of 125I-porcine insulin after 1 hr incubation at 20 ~ C (Fig. 4) . Both insulins at 2 ng/ml inhibited 20% of the 125I-porcine insulin binding. At 100 ng/ml, the binding of labelled insulin was inhibited by 55%. Chicken insulin appeared more potent than porcine insulin over the range of concentration tested (Fig. 4, left) . The higher potency of chicken insulin was significant (P < 0.01) after logit transformation of the data (Fig. 4, right) .
Apparent Number of Insulin-Binding Sites in Chicken Tissues
If we assume that the steady state of binding which is achieved by 60 min approximates equilibrium conditions, the plot shown in Figure 5 (MichaelisMenten type) gives the amount of insulin bound over a wide range of hormone concentration. However, because it is difficult to ascertain where true saturation occurs from this type of plot, Scatchard were calculated from competitive binding studies in which 125I-porcine insulin or 12SI-chicken insulin were mixed with increasing concentrations of unlabelled insulins. The amount of insulin nonspecifically bound (i. e., the percent of 125I-radioactivity bound in the presence of i0 or 100 gg unlabelled insulin • the insulin concentration) has been subtracted from each point. Since no great differences were observed in the binding of chicken or porcine insulin, data from each competitive binding curve were pooled in order to get more accurate means. Binding to chicken liver plasma membranes is the mean of 9 competitive binding curves obtained with 2 membrane preparations, binding to chicken hepatocytes is the mean of 4 competitive binding curves, and binding to chicken erytbrocytes is the mean of 3 competitive binding curves and Lineweaver-Burke analyses of the data were also performed (not shown) and the results are indicated in Table 3 . As could be expected, from the low level of binding of 125I-hormone observed in the three binding systems (liver membranes, liver cells and erythrocytes), the apparent maximal binding capacities and the corresponding number of binding sites were 3-6-fold lower in liver membranes (per mg of protein) and about 20-fold lower in hepatocytes (on a per cell basis) of the chicken than in liver membranes and hepatocytes of the rat, respectively (Table 3) . On the other hand, the apparent affinity of the chicken insulin receptor in isolated hepatocytes and in liver membranes (estimated from the concentration of insulin that corresponds to halfmaximal binding in Figure 5 , i.e., about 1.3 nM and 3.2 nM, respectively) was similar to that observed for the rat insulin receptor in hepatocytes (about 2 nM, see [17] and [32] ) and in liver membranes (about 3 nM, see [19] ). The possibility that the decreased insulin binding in chicken tissues (as compared to rat tissues) was due to a faster degradation of insulin can be ruled out since the percentage of 125I-hormone remaining intact in the incubation medium as measured by adsorption to talc [21] , exceeded 95% under the conditions used to measure the binding of insulin. We conclude that the lower binding of insulin in the chicken (as compared to the rat) is mainly accounted for by a lower number of insulin-binding sites.
Glucagon Binding in Chicken and Rat Liver Membranes
In an attempt to see whether glucagon-binding sites were also less numerous in chicken than in rat liver membranes, glucagon and insulin binding were measured in simultaneous experiments using the same membrane preparations from chicken and rat livers (Fig. 6) . Inhibition of 125I-glucagon binding by unlabelled gIucagon was not so marked in chicken as in rat liver membranes (Fig. 6, left) . Logit transformation of the data (Fig. 6, right) gave highly significant (P < 0.01) regression lines; but slopes differed significantly (P < 0.01). When the amount of insulin and glucagon specifically bound were calculated from these data (Fig. 7) , it was apparent that, at 5 ng hormone/ml, both hormones were bound to a lesser extent by chicken than by rat liver membranes. However at 100 ng hormone/ml, in contrast to glucagon, insulin binding remained lower in chicken than in rat liver membranes (Fig. 7) . These observations therefore, suggest that the reduced insulin binding capacity observed in chicken liver membranes (as compared to rat liver membranes) is rather selective for this hormone.
Discussion
In this study we examined the specific binding of insulin in chicken target tissues. The data indicate that, as in mammals, liver plasma membranes and [61ucagon],ng/ml Fig. 7 . Specific binding of chicken insulin and porcine glucagon in chicken and rat liver membranes as a function of hormone concentrations. These data were calculated from binding studies presented in Fig. 6 liver cells of the chicken possess specific insulinbinding sites with the properties (specificity, affinity and saturability) of biologically important receptors to the hormone. The results reported here also demonstrate the presence of specific insulin-binding sites in chicken erythrocytes. The insulin receptor has recently been characterized in erythrocyte membranes [28] and in intact erythrocytes [29] from the turkey.
Our results indicate that insulin receptors are less numerous in the chicken liver than in the rat liver. Since this was observed with 125I-chicken insulin as well as with 125I-porcine insulin, one can ascertain that the difference is related to chicken insulin receptors and not to the structural differences between chicken and porcine insulins. The lower insulin-binding in the chicken (as compared to the rat) was observed both in purified liver plasma membranes (per mg of membrane protein) and in isolated hepatocytes (on a per cell basis). Since the liver cell of the chicken (diameter: 12 ~tm, [24] is smaller than that of the rat (diameter: 23 ~m, [24] , a decrease in the number of insulin binding sites per cell would not necessarily result in a decrease in the density of the sites on the cell surface. Assuming that the isolated liver cell is a sphere, one can calculate, from the measurements of insulin binding in isolated chicken and rat hepatocytes (Table 3) , that the number of insulin receptors per unit surface area is approximately 5-fold lower in the chicken (about 10 sites/~tm 2) than in the rat (about 50 sites/[~m 2) liver cell. This agrees remarkably well with the 3-6-fold difference between the number of insulinbinding sites in the plasma membrane fraction of chicken and rat livers. In contrast to the marked difference in the number of sites, the apparent affinity of insulin binding in chicken hepatocytes and liver membranes was analogous to that observed in similar receptor preparations from the rat. This is in agreement with a recent study indicating that insulin receptors in turkey erythrocytes possess functional properties that are virtually identical to those of the mammalian insulin receptors [29] . These and other comparative studies suggest that the functional characteristics of the insulin receptor have remained remarkably constant despite evolutionary changes occuring in insulin structure [37] . It is indeed noteworthy that the variations in insulin binding which have thus far been reported among animal species have always been accounted for by changes in the number of binding sites (i. e., the binding capacity) rather than by alterations in the receptor affinity. For example, a higher insulin-binding capacity [17, 38] appears to be responsible for the higher binding of 125I-porcine insulin to liver membranes [17, 38] and various tissues [39] of the guinea pig when compared to the rat.
In view of our previous finding that chicken insulin had a higher binding affinity than porcine insulin in rat liver membranes [14, 15] , it would have been expected that chicken insulin would also exhibit a higher potency in binding to the chicken insulin receptor. This was not consistently observed, possibly because the level of insulin binding was too low, particularly in chicken hepatocytes, to permit discrimination between the binding potencies of the two insulins.
That chicken liver cells are equipped with insulin receptors that are less numerous than (although qualitatively similar to) those present in rat liver ceils may provide some explanation for the physiological state of relative insulin resistance which has been reported in the chicken. It is clear, from our results, that the decrease in insulin binding is observed whether the data are expressed per whole cell, per unit of cell surface area, or per mg of cell plasma membrane protein. This is a situation analogous to that observed in the obese hyperglycaemic (ob/ob) mouse when compared to the nonobese mouse (for review, see [17] ), a model of genetic obesity in which insulin resistance has been well documented. It may be anticipated that such a decrease in the concentration of insulin receptors will decrease the sensitivity of the target cell to insulin [17] . One may also speculate that the 2-fold higher binding affinity and biological potency [14] of chicken insulin (compared to porcine insulin) will not be sufficient to counterbalance a 5-fold lower density of insulin receptors in chicken cells. Therefore, there is a possibility that this decreased number and/or-concentration of insulin receptors in chicken cells is involved, partly at least, in some of the peculiarities of carbohydrate metabolism in the chicken, e.g., basal hyperglycaemia and relative insulin resistance. The low glucose content and glucose utilization in chicken erythrocytes [40] may also be relevant to this aspect. Studies aimed at relating insulin binding and insulin action in chicken tissues are certainly warranted.
